<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39363846</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2040-3372</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>04</Day></PubDate></JournalIssue><Title>Nanoscale</Title><ISOAbbreviation>Nanoscale</ISOAbbreviation></Journal><ArticleTitle>Cell invasive amyloid assemblies from SARS-CoV-2 peptides can form multiple polymorphs with varying neurotoxicity.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1039/d4nr03030c</ELocationID><Abstract><AbstractText>The neurological symptoms of COVID-19, often referred to as neuro-COVID include neurological pain, memory loss, cognitive and sensory disruption. These neurological symptoms can persist for months and are known as Post-Acute Sequalae of COVID-19 (PASC). The molecular origins of neuro-COVID, and how it contributes to PASC are unknown, however a growing body of research highlights that the self-assembly of protein fragments from SARS-CoV-2 into amyloid nanofibrils may play a causative role. Previously, we identified two fragments from the SARS-CoV-2 proteins, Open Reading Frame (ORF) 6 and ORF10, that self-assemble into neurotoxic amyloid assemblies. Here we further our understanding of the self-assembly mechanisms and nano-architectures formed by these fragments and their biological responses. By solubilising the peptides in a fluorinated solvent, we eliminate insoluble aggregates in the starting materials (seeds) that change the polymorphic landscape of the assemblies. The resultant assemblies are dominated by structures with higher free energies (<i>e.g.</i> ribbons and amorphous aggregates) that are less toxic to cultured neurons but do affect their mitochondrial respiration. We also show the first direct evidence of cellular uptake of viral amyloids. This work highlights the importance of understanding the polymorphic behaviour of amyloids and the correlation to neurotoxicity, particularly in the context of neuro-COVID and PASC.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sanislav</LastName><ForeName>Oana</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Anatomy, Physiology and Pharmacology, La Trobe University, Melbourne, Victoria 3086, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tetaj</LastName><ForeName>Rina</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute for Chemistry and Bioanalytics, School of Life Sciences, FHNW, Muttenz, 4132, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Chemistry, La Trobe University, Melbourne, Victoria 3086, Australia. nicholas.reynolds@latrobe.edu.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Metali</LastName><AffiliationInfo><Affiliation>Department of Biochemistry and Chemistry, La Trobe University, Melbourne, Victoria 3086, Australia. nicholas.reynolds@latrobe.edu.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ratcliffe</LastName><ForeName>Julian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Bio Imaging Platform, La Trobe University, Melbourne, Victoria 3086, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phillips</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Chemistry, La Trobe University, Melbourne, Victoria 3086, Australia. nicholas.reynolds@latrobe.edu.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klein</LastName><ForeName>Annaleise R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Australian Nuclear Science and Technology Organisation (ANSTO), Australian Synchrotron, Clayton, Victoria 3168, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sethi</LastName><ForeName>Ashish</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Australian Nuclear Science and Technology Organisation (ANSTO), Australian Synchrotron, Clayton, Victoria 3168, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Jiangtao</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-4248-2207</Identifier><AffiliationInfo><Affiliation>Department of Health Sciences and Technology, ETH Zurich, Schmelzbergstrasse 9, LFO, E23, 8092, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mezzenga</LastName><ForeName>Raffaele</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-5739-2610</Identifier><AffiliationInfo><Affiliation>Department of Health Sciences and Technology, ETH Zurich, Schmelzbergstrasse 9, LFO, E23, 8092, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Materials, ETH Zurich, Zurich, 8093, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saxer</LastName><ForeName>Sina S</ForeName><Initials>SS</Initials><Identifier Source="ORCID">0000-0002-7101-0623</Identifier><AffiliationInfo><Affiliation>Institute for Chemistry and Bioanalytics, School of Life Sciences, FHNW, Muttenz, 4132, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Charnley</LastName><ForeName>Mirren</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Optical Sciences Centre, Swinburne University of Technology, Hawthorn, Victoria 3122, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Immune Signalling Laboratory, Peter MacCallum Cancer Centre, Parkville, Victoria 3000, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Annesley</LastName><ForeName>Sarah J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Anatomy, Physiology and Pharmacology, La Trobe University, Melbourne, Victoria 3086, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reynolds</LastName><ForeName>Nicholas P</ForeName><Initials>NP</Initials><Identifier Source="ORCID">0000-0003-4360-1335</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry and Chemistry, La Trobe University, Melbourne, Victoria 3086, Australia. nicholas.reynolds@latrobe.edu.au.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Biomedical and Environmental Sensor Technology (BEST) Research Centre, Biosensors Program, La Trobe Institute for Molecular Science (LIMS), La Trobe University, Melbourne, Victoria 3086, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nanoscale</MedlineTA><NlmUniqueID>101525249</NlmUniqueID><ISSNLinking>2040-3364</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>8</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>8</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>4</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39363846</ArticleId><ArticleId IdType="doi">10.1039/d4nr03030c</ArticleId></ArticleIdList></PubmedData></PubmedArticle>